NCT04924972 is a clinical trial of Blepharoplasty in Dermatochalasis of Upper Eyelid, sponsored by Medical University of Vienna.

Who is sponsoring NCT04924972?

NCT04924972 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04924972?

Interventions in NCT04924972: Blepharoplasty.

What condition does NCT04924972 study?

NCT04924972 studies Dermatochalasis of Upper Eyelid.

Is NCT04924972 still recruiting?

NCT04924972 is currently completed. Last updated 2 September 2022.

Last reviewed 2022-09-02 · How we verify

NCT04924972

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FACE-Q in Blepharoplasty

Completed Last updated 2 September 2022

What this trial tests

trial testing Blepharoplasty in Dermatochalasis of Upper Eyelid in 90 participants. Completed in 1 September 2022.

Timeline

1 February 2019

Primary endpoint
13 July 2022

1 September 2022

Quick facts

Lead sponsor	Medical University of Vienna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	90
Start date	1 February 2019
Primary completion	13 July 2022
Estimated completion	1 September 2022
Sites	1 location across Austria

Drugs / interventions tested

Blepharoplasty

Conditions studied

Dermatochalasis of Upper Eyelid — all drugs for Dermatochalasis of Upper Eyelid →

Sponsor

Medical University of Vienna

Who can join

Adults 18 to 99, any sex, with Dermatochalasis of Upper Eyelid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the effect of two different suturing techniques in patients undergoing bilateral upper eyelid blepharoplasty on the results of the FACE-Q Eye Module questionnaire for measuring patient-reported outcomes as well as on the blinded objective assessment by two experienced surgeons using the same questionnaire. We aim to investigate the differences of the 2 most common techniques of skin closure with running cutaneous or subcuticular Nylon (6-0 Prolene) sutures in upper blepharoplasties and their effect on postoperative complications and scar formation. Besides the functional outcomes (visual field) and objective postoperative results, we aim to measure the patients' satisfaction using the FACE-Q Eye Module as a comprehensive, procedure- and disease-specific patient-reported outcome instrument.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

FACE-Q Patient Report-Assisted Subjective and Objective Evaluation of Blepharoplasty Outcomes Using Two Different Suturing Techniques: A Randomized and Patient-Blinded Pilot Study.
Told R, Placheta-Györi E, Lackner B, Kuchar A, et al · · 2023 · cited 5× · PMID 37127811 · DOI 10.1007/s00266-023-03339-6

Verify or expand the search:

Other trials of Blepharoplasty

Trials testing the same drug.

NCT06047418 — Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation · completed

Other recruiting trials for Dermatochalasis of Upper Eyelid

Currently open trials in the same condition.

NCT07250139 — Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation · NA · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04924972 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 2 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04924972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing